FORT MYERS — Florida Cancer Specialists and Research Institute, a network of oncologists, has named six physicians to its executive board.
The doctors, according to a statement, are: Dr. Ahmed Al-Hazzouri, Dr. Matthew Fink, Dr. Faithlore Gardner, Dr. Alexander Glick, Dr. Sachar Peles and Dr. Mary Li. The executive board oversees the strategic direction and operational decision-making for the statewide oncology practice. There are now 14 people on the executive board, including FCS President and Managing Physician Dr. Lucio Gordan and Dr. Michael Diaz.
“Our executive board fulfills a mission critical role in ensuring that we are not only meeting the highest ethical and clinical standards across our industry but are also performing day in and day out for our patients,” FCS CEO Nathan Walcker says in the statement. “The oncology landscape is rapidly evolving, and I look forward to partnering with our new executive board members to advance the mission of Florida Cancer Specialists in bringing leading treatments, terrific physicians and high-quality care to the doorsteps of more Floridians in their communities.”
“We are grateful to our colleagues for their willingness to assume this leadership role and guide our future initiatives to advance the delivery of world-class cancer care,” adds Gordan in the statement.
FCS, with more than 230 physicians, 220 advanced practice registered nurses and physician assistants and some 100 locations statewide, is also now one of the biggest oncology practices in Florida. It did $2.1 billion in revenue and collections in 2017, the last year it publicly disclosed revenue.